Prevention of leukemia relapse by donor activating KIR2DS1

N Engl J Med. 2012 Nov 22;367(21):2054-5; author reply 2055. doi: 10.1056/NEJMc1211673.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • HLA-C Antigens / genetics*
  • Humans
  • Leukemia, Myeloid, Acute / prevention & control*
  • Receptors, KIR / genetics*

Substances

  • HLA-C Antigens
  • Receptors, KIR